Isaac Eliaz

CEO

Physician and innovator in conventional and integrative medicine with 30+ years in Galectin-3 research. Founded a high-impact venture acquired by a private equity firm (AUM $22B+), holds 60+ patents, and is driven to create transformative global impact.

Kristin Nuckols

Co-Founder & Chief Clinical Officer

Award-winning occupational therapist. Led stroke teams in top rehab hospitals. Former Harvard researcher. Developed Imago’s clinical protocol with 5X+ motor gains. James Madison University MOT. Boston University OTD.

Jim Iversen

Co-Founder, CEO

Serial entrepreneur and innovative disruptor. 5 exits at $80M. Scaled companies from 0-160 employees and to $50M revenue at W&H Systems, Mincron, and AL Systems. Seasoned CEO and global humanitarian. BS Mechanical Engineering.

Jeff Dachis

Founder and CEO

A proven track record of successful entrepreneurship and disruptive innovation and over a decade of experience in digital design and the diabetes industry

Anan Copty

CEO

25+ years of technical & leadership experiences, RMD: Radiation Monitoring Devices, Intel: Biochips, Harvard Medical School: MRI

Roslynn L Steiner

CEO and President

Led SteinerBio’s rise as an innovative leader in maxillofacial bone grafts with science-based, patient-focused solutions

Ben Chang

CEO/Director

Mr. Chang has over 30 years of pharmaceutical and executive-level experience. He also has experience in international banking, venture capital, M&A, finance, go-public transactions, and organizational design and operations. He holds 2 patents.

Carlos Rodriguez

CEO and Co-Founder

20 years of progressive healthcare management experience. Carlos started his first business in 2012 in the Health Information Management space and grew the start up to $40 million dollars in annual revenue before selling it to Venture Capital Firm.